Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.

Accepted 2022-03-23 00:00:00 ET · period of report 2022-03-18 · accession 0001104659-22-037189 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2022-03-23	2022-03-18	SUPN	Khattar Jack A.	Pres, CEO, Dir	J - Other	—	+10.8K	627.2K	+2%	—
I	2022-03-23	2022-03-18	SUPN	Khattar Jack A.	Pres, CEO, Dir	J - Other	—	-10.8K	1.05M	-1%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-18	J	A	10,750	—	627,216	D By the KBT Trust	—	—	(F1) The Reporting Person was first notified of the completed transaction by the transfer agent on the filing date. (F2) The Reporting Person is filing this Form 4 to reflect the fact that 10,750 shares were transferred from the KBT Trust to the Reporting Person on March 18, 2022 without consideration and are now owned directly.
2	Common	Common Stock	2022-03-18	J	D	10,750	—	1,047,700	I	—	—	(F1) The Reporting Person was first notified of the completed transaction by the transfer agent on the filing date. (F2) The Reporting Person is filing this Form 4 to reflect the fact that 10,750 shares were transferred from the KBT Trust to the Reporting Person on March 18, 2022 without consideration and are now owned directly.